̽»¨¾«Ñ¡

Consultant in Hepatology at the Karolinska University Hospital and Professor and group leader for the Hagström group at ̽»¨¾«Ñ¡.

Co-director for Center for Bioinformatics and Biostatistics (CBB) at KI South

2016 the Bengt Ihre scholarship

2018 AASLD Early Career Investigator Award

2024 UEG Rising Star Award

My main focus is liver-related epidemiology, with a specific interest in steatotic liver disease. Key questions that my group focuses on include long-term outcomes of steatotic liver disease, now the most common chronic liver disease with a global prevalence of more than 30%. We aim to identify risk factors for disease progression. I have been instrumental in developing one of the globally largest cohorts of patients with steatotic liver disease. We use a combination of well-phenotyped patient cohorts with large-scale epidemiology and have several collaborations with basic scientists and international colleagues. Some current initiatives include the Fatty Liver In Sweden multi-center cohort of longitudinally examined patients, and the screening initiative SCANDIA where 1000 patients with type 2 diabetes have been screened for presence and severity of fatty liver disease.

I am currently the main supervisor of five PhD-students and two postdocs. Regular bedside teaching of ̽»¨¾«Ñ¡ students. Frequent (over 15) supervisor of master thesis in research for ̽»¨¾«Ñ¡ students.